Latham & Watkins LLP represented the underwriters in the offering. Sigilon Therapeutics, Inc. (Nasdaq: SGTX) has announced its upsized initial public offering of 7,000,000 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
